Biomea Fusion (BMEA) Assets (2020 - 2026)
Biomea Fusion (BMEA) posted Assets of $46.4 million for Q1 2026, down 20.81% sequentially from $58.6 million in Q4 2025, and down 15.75% YoY from $55.1 million in Q1 2025.
Biomea Fusion (BMEA) Assets (2020 - 2026) Analysis & Trends
Biomea Fusion has reported Assets for 7 years, with the latest figure at $46.4 million in Q1 2026.
- Quarterly Assets fell 15.75% year-over-year to $46.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.4 million (down 15.75% YoY) and the FY2025 annual result came in at $58.6 million, down 26.73% from the prior year.
- Assets fell to $46.4 million in Q1 2026 per BMEA's latest filing, from $58.6 million in the prior quarter.
- Over five years, Assets peaked at $248.7 million in Q2 2023 and troughed at $46.4 million in Q1 2026.
- A 5-year average of $128.3 million and a median of $129.3 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets jumped 192.05% in 2022, then tumbled 67.33% in 2025.
- Over 5 years, Assets stood at $129.3 million in 2022, then jumped by 54.61% to $199.9 million in 2023, then plunged by 60.02% to $79.9 million in 2024, then declined by 26.73% to $58.6 million in 2025, then declined by 20.81% to $46.4 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $46.4 million, $58.6 million, and $55.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - | 36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.87 Mn |
| Mar 31, 2026 | 46.39 Mn |
| Dec 31, 2025 | 58.57 Mn |
| Sep 30, 2025 | 55.19 Mn |
| Jun 30, 2025 | 73.16 Mn |
| Mar 31, 2025 | 55.06 Mn |
| Dec 31, 2024 | 79.94 Mn |
| Sep 30, 2024 | 110.42 Mn |
| Jun 30, 2024 | 136.16 Mn |
| Mar 31, 2024 | 168.49 Mn |
| Dec 31, 2023 | 199.93 Mn |
| Sep 30, 2023 | 225.09 Mn |
| Jun 30, 2023 | 248.67 Mn |
| Mar 31, 2023 | 112.64 Mn |
| Dec 31, 2022 | 129.31 Mn |
| Sep 30, 2022 | 145.05 Mn |
| Jun 30, 2022 | 161.74 Mn |
| Mar 31, 2022 | 174.86 Mn |
| Dec 31, 2021 | 185.71 Mn |
| Sep 30, 2021 | 199.40 Mn |